Frizzled class G protein-coupled receptor (FZD) (FZD)

Frizzled class G protein-coupled receptors (FZDs) are a group of ten highly conserved seven-transmembrane proteins that act as the principal receptors for Wnt signaling ligands (UniProt, 2024). These receptors are essential for coordinating complex biological processes including embryonic development, cell polarity, and adult tissue homeostasis through both canonical beta-catenin and non-canonical signaling pathways (PubMed, PMC2690239). In many pathological contexts, particularly oncology, Frizzled receptors are often overexpressed or dysregulated, promoting tumor progression, epithelial-mesenchymal transition, and the maintenance of cancer stem cells (Nature Reviews Cancer, 2017). Because of their central role in oncogenic signaling, FZDs have become prominent targets for therapeutic intervention, with agents like the monoclonal antibody Vantictumab entering clinical trials to treat solid tumors (ClinicalTrials.gov, NCT01345201). The interaction between Wnt ligands and the extracellular cysteine-rich domain of Frizzled receptors triggers downstream cascades that regulate gene expression and cytoskeletal organization (NCBI, NBK9848). However, the therapeutic window for Frizzled-targeted drugs is narrow due to the receptors' vital roles in normal physiology, such as maintaining bone density and intestinal epithelium integrity (StatPearls, 2023). Clinical challenges include managing side effects like bone mineral density loss, which has been observed in trials involving pan-Frizzled inhibitors (Journal of Clinical Oncology, 2015). Current research focuses on developing more selective inhibitors or bispecific antibodies to mitigate systemic toxicities while effectively blocking pathological Wnt signaling in specific tissues.

Other names

Frizzled family receptorFzWnt receptorFrizzled-like receptor

Antagonism of Wnt ligand binding to the extracellular cysteine-rich domain of Frizzled receptors, thereby inhibiting both canonical beta-catenin-dependent and non-canonical signaling pathways.